Role of ABCC5 in Gemcitabine Resistance in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid tumours. gemcitabine-based regimens have been used as front-line treatments for patients with advanced pancreatic cancer. gemcitabine may initially show a response, but most often multi-drug resistance (MDR) rapidly develops...
Main Author: | |
---|---|
Other Authors: | , , |
Format: | Others |
Published: |
Auckland University of Technology,
2019-07-16T23:09:08Z.
|
Subjects: | |
Online Access: | Get fulltext |